<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:hpo ids='HP_0002138'>Subarachnoid hemorrhage</z:hpo> (SAH) causes dynamic changes in cerebral blood flow (CBF), and results in delayed <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> due to vasospasm, and early perfusion deficits before delayed <z:e sem="disease" ids="C0265110" disease_type="Disease or Syndrome" abbrv="">cerebral vasospasm</z:e> (CVS) </plain></SENT>
<SENT sid="1" pm="."><plain>The present study examined the severity of cerebral circulatory disturbance during the early phase before delayed CVS and whether it can be used to predict patient outcome </plain></SENT>
<SENT sid="2" pm="."><plain>A total of 94 patients with SAH underwent simultaneous <z:chebi fb="3" ids="49957">xenon</z:chebi> computed tomography (CT) and perfusion CT to evaluate cerebral circulation on Days 1-3 </plain></SENT>
<SENT sid="3" pm="."><plain>Cerebral blood flow (CBF) was measured using <z:chebi fb="3" ids="49957">xenon</z:chebi> CT and the mean transit time (<z:chebi fb="0" ids="53233">MTT</z:chebi>) using perfusion CT and calculated cerebral blood volume (CBV) </plain></SENT>
<SENT sid="4" pm="."><plain>Outcome was evaluated with the Glasgow Outcome Scale (good recovery [GR], moderate disability [MD], severe disability [SD], <z:e sem="disease" ids="C0917808" disease_type="Disease or Syndrome" abbrv="">vegetative state</z:e> [VS], or <z:hpo ids='HP_0011420'>death</z:hpo> [D]) </plain></SENT>
<SENT sid="5" pm="."><plain>Hunt and Hess (HH) grade II patients displayed significantly higher CBF and lower <z:chebi fb="0" ids="53233">MTT</z:chebi> than HH grade IV and V patients </plain></SENT>
<SENT sid="6" pm="."><plain>HH grade III patients displayed significantly higher CBF and lower <z:chebi fb="0" ids="53233">MTT</z:chebi> than HH grade IV and V patients </plain></SENT>
<SENT sid="7" pm="."><plain>Patients with favorable outcome (GR or MD) had significantly higher CBF and lower <z:chebi fb="0" ids="53233">MTT</z:chebi> than those with unfavorable outcome (SD, VS, or D) </plain></SENT>
<SENT sid="8" pm="."><plain>Discriminant analysis of these parameters could predict patient outcome with a probability of 74.5% </plain></SENT>
<SENT sid="9" pm="."><plain>Higher HH grade on admission was associated with decreased CBF and CBV and prolonged <z:chebi fb="0" ids="53233">MTT</z:chebi> </plain></SENT>
<SENT sid="10" pm="."><plain>CBF reduction and <z:chebi fb="0" ids="53233">MTT</z:chebi> prolongation before the <z:hpo ids='HP_0003674'>onset</z:hpo> of delayed CVS might influence the clinical outcome of SAH </plain></SENT>
<SENT sid="11" pm="."><plain>These parameters are helpful for evaluating the severity of SAH and predicting the outcomes of SAH patients </plain></SENT>
</text></document>